Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Cryptosporidium parvum Activators

Cryptosporidium parvum, a microscopic protozoan parasite belonging to the Apicomplexa phylum, has garnered attention for its impact on waterborne diseases and gastrointestinal infections. The activation mechanisms of Cryptosporidium parvum are complex and multifaceted, involving various environmental factors and host interactions. These activators play a critical role in the parasite's life cycle and pathogenicity. One key activator for Cryptosporidium parvum is the host's immune status. When an individual's immune system is compromised, either due to a weakened immune response or an immunosuppressive condition, it provides an environment in which the parasite can thrive and replicate. Additionally, host factors such as age, nutrition, and genetics can influence susceptibility to infection, acting as activators by either facilitating or hindering the parasite's establishment within the host.

Furthermore, environmental factors also serve as significant activators for Cryptosporidium parvum. This parasite is highly resilient and can persist in a variety of settings, including water sources. Contaminated water serves as a crucial activator for the transmission of Cryptosporidium parvum. Temperature and humidity can also impact the parasite's survival and transmission, making climatic conditions additional activators. In conclusion, Cryptosporidium parvum activators encompass a broad spectrum of host and environmental factors that influence the parasite's life cycle and pathogenicity, contributing to the challenges in managing infections caused by this protozoan parasite. Understanding these activators is crucial for public health efforts aimed at reducing the prevalence of Cryptosporidium parvum-related illnesses.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Cyclosporin A is an immunosuppressant, and its use might indirectly activate Cryptosporidium parvum by suppressing the host's immune response, allowing the parasite to proliferate.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin, a PI3-kinase inhibitor, may indirectly activate Cryptosporidium parvum by modulating signaling pathways involved in host-parasite interactions.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580, a p38 MAPK inhibitor, could indirectly activate Cryptosporidium parvum by altering host cell responses and signaling pathways.

JAK Inhibitor I

457081-03-7sc-204021
sc-204021A
500 µg
1 mg
$156.00
$339.00
59
(1)

This Janus kinase inhibitor may indirectly activate Cryptosporidium parvum by modulating signaling pathways in the host, potentially affecting the parasite's activation.

N-Acetyl-L-cysteine

616-91-1sc-202232
sc-202232A
sc-202232C
sc-202232B
5 g
25 g
1 kg
100 g
$34.00
$74.00
$270.00
$114.00
34
(1)

NAC, an antioxidant, may activate Cryptosporidium parvum indirectly by reducing oxidative stress and altering host-parasite interactions.

2-APB

524-95-8sc-201487
sc-201487A
20 mg
100 mg
$28.00
$53.00
37
(1)

2-APB, an IP3 receptor inhibitor, might indirectly activate Cryptosporidium parvum by interfering with host cell calcium signaling, which the parasite relies on.

Z-VAD-FMK

187389-52-2sc-3067
500 µg
$75.00
256
(6)

Z-VAD-FMK, a caspase inhibitor, may indirectly activate Cryptosporidium parvum by modulating host cell apoptosis, which can be exploited by the parasite during infection.